Self-reported psychological development in cosmetic breast surgery patients

Cosmetic breast surgery is the only therapeutic alternative for psychological and physical complications associated with micromasty, breast ptosis, and macromasty. We analyzed the effects of 2 variables, time, and type of cosmetic breast surgery, on anxiety symptomatology and quality of life. Following a mixed 3x4 design, 3 groups of women with breast augmentation (n=63), mastopexy (n=42), and breast reduction (n=30) were selected and evaluated using the State-Trait Anxiety Inventory and the 12-Item Short-Form Health Survey at 4 different times, the preoperative stage, and at 1, 6, and 12 months postoperative. Pearson’s chi square, Welch’s U, Games-Howell tests, mixed analysis of variance, and Cohen’s d and w for effect size were calculated. Results relating to anxiety (state and trait) showed that the time factor was significant (P<0.001) with differences between the preoperative stage (higher anxiety levels) and the 3 postoperative stages: at 1 month (P<0.001), 6 months (P<0.001), and 12 months (P<0.001). In quality of life, type of surgery and time factors were found to have interactive effects on vitality (P=0.044) and role-emotional (P=0.023) dimensions. Compared to the other 2 groups, women who had undergone mastopexy felt worse (vitality) at 1 month since surgery than in the other stages, and better at 6 months since surgery (role-emotional). In the rest of the dimensions, and focusing on the most relevant effect sizes, the type of surgery made a difference in the physical functioning (P=0.005) and role-physical (P=0.020) dimensions, where women who had had breast reduction felt worse than those who had had augmentation. Time also resulted in differences in the physical functioning (P<0.001), role-physical (P<0.001), and bodily pain (P<0.001) dimensions, where women felt worse at 1 month since surgery than during the rest of the stages, as well as in the social functioning dimension (P